Ryman Healthcare’s former chief development officer, Andrew Mitchell, whose departure was announced last month, has sold all his stock in the company for $2.6 million.
The June 4 transaction at an average $11.61 a share was disclosed to the NZX on Friday and featured the on-market sale of
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
